Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

Clicks: 476
ID: 117933
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Routine RV1 vaccination in Botswana showed effectiveness similar to that in clinical trials in Africa, including against a serotype fully heterotypic to the vaccine. Undernutrition may in part explain the lower rotavirus VE in low-income settings.
Reference Key
pa2016clinicaleffectiveness Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gastañaduy PA;Steenhoff AP;Mokomane M;Esona MD;Bowen MD;Jibril H;Pernica JM;Mazhani L;Smieja M;Tate JE;Parashar UD;Goldfarb DM;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27059351
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't u.s. gov't female male Child Infant Prospective Studies P.H.S. preschool Diarrhea / epidemiology Genotype diarrhea / prevention & control* case-control studies diarrhea / virology* hospitalization rotavirus infections / epidemiology rotavirus infections / prevention & control* rotavirus infections / virology rotavirus vaccines / administration & dosage rotavirus vaccines / immunology* vaccine potency vaccines attenuated / administration & dosage attenuated / immunology malnutrition / epidemiology rotavirus / immunology feces / virology pmid:27059351 doi:10.1093/cid/civ1207 paul a gastañaduy andrew p steenhoff david m goldfarb botswana / epidemiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.